ClinicalTrials.Veeva

Menu

NitrX Total Knee Arthroplasty RSA

L

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Status

Active, not recruiting

Conditions

Radiostereometric Analysis
Knee Osteoarthritis
Total Knee Arthroplasty

Treatments

Device: Total Knee Arthroplasty with Evolution Knee System
Device: Total Knee Arthroplasty with Evolution® NitrX™ Knee System

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

Metal hypersensitivity is a recognized complication in some patients following total joint arthroplasty. This can result in a reaction to metal particles from the implants placed in the joint and cause tissue injury. The Evolution® NitrX™ (MicroPort Orthopaedics, Memphis, TN) knee implant was designed with the addition of a coating meant to create a barrier against the release of metal ions. The primary purpose of this study is to compare the Evolution and Evolution NitrX implant (implants your surgeon uses in total knee arthroplasty surgery). This study will compare the stability of these knee implants (any movement the implant makes after surgery) through the use of specialized xrays, called "radiostereometric analysis" (RSA for short). The investigators will also compare levels of circulating metal particles with blood draws and the effects of any circulating metal with MR imaging. The investigators will also be looking at the participants clinical outcomes using joint function and patient satisfaction questionnaires. A total of 50 patients will be enrolled into the study.

Enrollment

50 estimated patients

Sex

All

Ages

21 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty
  • Varus knee deformity of 0 to 10 degrees
  • Sufficient ligamentous function to warrant retention of the posterior cruciate ligament
  • Between ages of 21 and 80 inclusive
  • Patients willing and able to comply with follow-up requirements and self-evaluations
  • Ability to give informed consent
  • No contraindications to Magnetic Resonance Imaging (MRI)

Exclusion criteria

  • Active or previous infection
  • Medical condition precluding major surgery
  • Inflammatory arthropathy
  • Prior Patellectomy
  • PCL deficiency
  • Major Coronal plane deformity
  • Valgus deformity
  • Bone defects requiring augments, cones and/or stemmed implants

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Evolution Total Knee Arthroplasty system
Active Comparator group
Description:
Patients will undergo total knee arthroplasty with the Evolution Total Knee System
Treatment:
Device: Total Knee Arthroplasty with Evolution Knee System
Evolution with NitrX Total Knee Arthroplasty system
Experimental group
Description:
Patients will undergo total knee arthroplasty with the NitrX Evolution Total Knee System which has the specialized protective coating
Treatment:
Device: Total Knee Arthroplasty with Evolution® NitrX™ Knee System

Trial contacts and locations

1

Loading...

Central trial contact

Janel Dhooma, MPH; Lyndsay Somerville, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems